What is Fusion Pharmaceuticals Inc.'s current stock price?

Fusion Pharmaceuticals Inc. (DFFN) currently trades at USD 4.40. Track real-time price changes and historical performance on AllInvestView.

What sector is Fusion Pharmaceuticals Inc. in?

Fusion Pharmaceuticals Inc. operates in the Health Care sector. AllInvestView lets you analyze sector allocation across your entire portfolio.

Fusion Pharmaceuticals Inc. DFFN · Stock Open Fusion Pharmaceuticals Inc. in new tab

4.40 USD

Add to portfolio

1M 6M YTD 1Y 2Y 5Y Max

Loading chart...

DCF Valuation

Tweak assumptions to recompute fair value for Fusion Pharmaceuticals Inc. (DFFN)

Currency: USD

DCF Assumptions

Revenue growth (YoY) 0.10 Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).

EBITDA margin 0.30 Decimal (e.g., 0.30 = 30%).

Capex (% Revenue) 0.04 Decimal (e.g., 0.04 = 4%).

Tax rate 0.20 Decimal (e.g., 0.20 = 20%).

Terminal growth (g, %) 3% Percent number (e.g., 3 = 3%).

Cost of Equity (%) 10% Percent number (e.g., 10 = 10%).

Cost of Debt (%) 5% Percent number (e.g., 5 = 5%).

DCF Result

Fair Value (DCF)

—

Current Price

—

Upside

—

WACC

—

Terminal PV

—

Σ PV of FCFs

—

Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Fusion Pharmaceuticals Inc. Analysis (DFFN)

Canada Health Care Official Website Stock

Is Fusion Pharmaceuticals Inc. a good investment? Fusion Pharmaceuticals Inc. (DFFN) is currently trading at 4.40 USD.

Investor FAQ

Does Fusion Pharmaceuticals Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Fusion Pharmaceuticals Inc.?

Fusion Pharmaceuticals Inc. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

Company Profile

Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia.

Exchange Ticker

NMS (United States) DFFN

NMS (United States) CRVO

Trades

No dividend information available for this instrument.

Fusion Pharmaceuticals Inc. DFFN · Stock Open Fusion Pharmaceuticals Inc. in new tab

DCF Valuation

DCF Assumptions

DCF Result

Explore Premium Features

Fusion Pharmaceuticals Inc. Analysis (DFFN)

Investor FAQ

Company Profile

Fundamentals

Under Construction

Fusion Pharmaceuticals Inc. DFFN · Stock Open Fusion Pharmaceuticals Inc. in new tab

DCF Valuation

DCF Assumptions

DCF Result

Explore Premium Features

Fusion Pharmaceuticals Inc. Analysis (DFFN)

Investor FAQ

Company Profile

Explore Premium Features

Fundamentals

Under Construction

Community Discussion

Notifications